ES550482A0 - Un procedimiento para preparar un derivado de benzofurano - Google Patents
Un procedimiento para preparar un derivado de benzofuranoInfo
- Publication number
- ES550482A0 ES550482A0 ES550482A ES550482A ES550482A0 ES 550482 A0 ES550482 A0 ES 550482A0 ES 550482 A ES550482 A ES 550482A ES 550482 A ES550482 A ES 550482A ES 550482 A0 ES550482 A0 ES 550482A0
- Authority
- ES
- Spain
- Prior art keywords
- group
- sup
- carbon atoms
- hydrogen atom
- unsubstituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D307/80—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D307/85—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/86—Benzo [b] furans; Hydrogenated benzo [b] furans with an oxygen atom directly attached in position 7
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Furan Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP28080184 | 1984-12-29 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES550482A0 true ES550482A0 (es) | 1987-05-16 |
| ES8705871A1 ES8705871A1 (es) | 1987-05-16 |
Family
ID=17630158
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES550482A Expired ES8705871A1 (es) | 1984-12-29 | 1985-12-27 | Un procedimiento para preparar un derivado de benzofurano |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US4666931A (es) |
| EP (1) | EP0187387B1 (es) |
| JP (1) | JPS62155269A (es) |
| AT (1) | ATE37544T1 (es) |
| CA (1) | CA1260947A (es) |
| DE (1) | DE3565262D1 (es) |
| ES (1) | ES8705871A1 (es) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL83215A (en) * | 1986-07-23 | 1991-12-15 | Lilly Co Eli | Synthesis of bicyclic heteroaromatic sulfonyl chlorides |
| JP2764262B2 (ja) * | 1987-08-28 | 1998-06-11 | 持田製薬株式会社 | ヒダントイン誘導体及びそれを有効成分とする医薬組成物 |
| US5004751A (en) * | 1987-08-28 | 1991-04-02 | Mochida Pharmaceutical Co., Ltd. | Hydantoin derivatives |
| US5202339A (en) * | 1987-08-28 | 1993-04-13 | Mochida Pharmaceutical Co., Ltd. | Hydantoin derivatives |
| JPH01100164A (ja) * | 1987-10-12 | 1989-04-18 | Shionogi & Co Ltd | スルファモイル−2−ベンゾフランカルボン酸誘導体 |
| WO1990002126A1 (en) * | 1988-08-24 | 1990-03-08 | Mochida Pharmaceutical Co., Ltd. | Hydantoin derivatives |
| US5441984A (en) * | 1994-01-06 | 1995-08-15 | Eli Lilly And Company | Urea, thiourea and guanidine derivatives |
| EP0873331B1 (en) * | 1995-12-05 | 2002-04-03 | Darwin Discovery Limited | Benzofuran carboxamides and sulphonamides |
| DE69737605T2 (de) * | 1996-01-23 | 2008-04-03 | Shionogi & Co., Ltd. | Sulfonierte aminosäurederivate und metalloproteinase-inhibitoren, die diese enthalten |
| CZ371998A3 (cs) * | 1996-05-20 | 1999-03-17 | Darwin Discovery Limited | Benzofuranové karboxamidy a jejich terapeutické použití |
| US20040043224A1 (en) * | 2002-08-30 | 2004-03-04 | Shmuel Sternberg | Enhanced hydrophobic membranes and methods for making such membranes |
| FR2958290B1 (fr) | 2010-03-30 | 2012-10-19 | Sanofi Aventis | Procede de preparation de derives de sulfonamido-benzofurane |
| FR2958291B1 (fr) * | 2010-04-01 | 2013-07-05 | Sanofi Aventis | Procede de preparation de derives d'amino-benzofurane |
| HUP1000330A2 (en) | 2010-06-18 | 2011-12-28 | Sanofi Sa | Process for the preparation of dronedarone and the novel intermediates |
| WO2012011314A1 (ja) * | 2010-07-22 | 2012-01-26 | 扶桑薬品工業株式会社 | ベンゾフラノン化合物およびそれを含む医薬組成物 |
| HUP1100167A2 (en) | 2011-03-29 | 2012-11-28 | Sanofi Sa | Process for preparation of dronedarone by mesylation |
| HUP1100165A2 (en) | 2011-03-29 | 2012-12-28 | Sanofi Sa | Process for preparation of dronedarone by n-butylation |
| FR2983198B1 (fr) | 2011-11-29 | 2013-11-15 | Sanofi Sa | Procede de preparation de derives de 5-amino-benzoyl-benzofurane |
| EP2617718A1 (en) | 2012-01-20 | 2013-07-24 | Sanofi | Process for preparation of dronedarone by the use of dibutylaminopropanol reagent |
| US9221778B2 (en) | 2012-02-13 | 2015-12-29 | Sanofi | Process for preparation of dronedarone by removal of hydroxyl group |
| WO2013121234A1 (en) | 2012-02-14 | 2013-08-22 | Sanofi | Process for the preparation of dronedarone by oxidation of a sulphenyl group |
| US9382223B2 (en) | 2012-02-22 | 2016-07-05 | Sanofi | Process for preparation of dronedarone by oxidation of a hydroxyl group |
| WO2013178337A1 (en) | 2012-05-31 | 2013-12-05 | Sanofi | Process for preparation of dronedarone by grignard reaction |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2697719A (en) * | 1948-07-31 | 1954-12-21 | Upjohn Co | N-arylsulfonyl p-aminobenzoyl glutamates |
| JPS5745185A (en) * | 1980-07-21 | 1982-03-13 | Eisai Co Ltd | Hydantoin derivative and its preparation |
| DE3110009A1 (de) * | 1981-03-11 | 1982-09-30 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Neue benzofuran-derivate, ihre herstellung und verwendung |
| NZ201219A (en) * | 1981-07-28 | 1984-10-19 | Reckitt & Colmann Prod Ltd | Dihydrobenzofuranyl-2-imidazolines and pharmaceutical compositions |
| US4544667A (en) * | 1984-02-09 | 1985-10-01 | Merck & Co., Inc. | 2-Sulfamoylbenzo[b]furan derivatives for the treatment of elevated intraocular pressure |
-
1985
- 1985-12-27 US US06/814,135 patent/US4666931A/en not_active Expired - Fee Related
- 1985-12-27 ES ES550482A patent/ES8705871A1/es not_active Expired
- 1985-12-27 JP JP60298622A patent/JPS62155269A/ja active Granted
- 1985-12-27 CA CA000498703A patent/CA1260947A/en not_active Expired
- 1985-12-28 DE DE8585116638T patent/DE3565262D1/de not_active Expired
- 1985-12-28 EP EP85116638A patent/EP0187387B1/en not_active Expired
- 1985-12-28 AT AT85116638T patent/ATE37544T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE3565262D1 (en) | 1988-11-03 |
| EP0187387B1 (en) | 1988-09-28 |
| JPS62155269A (ja) | 1987-07-10 |
| CA1260947A (en) | 1989-09-26 |
| EP0187387A1 (en) | 1986-07-16 |
| ATE37544T1 (de) | 1988-10-15 |
| ES8705871A1 (es) | 1987-05-16 |
| JPH0584316B2 (es) | 1993-12-01 |
| US4666931A (en) | 1987-05-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES550482A0 (es) | Un procedimiento para preparar un derivado de benzofurano | |
| US4296039A (en) | Selected process for producing monohalogenated derivatives of 7-hydroxy-coumarin | |
| US4681893A (en) | Trans-6-[2-(3- or 4-carboxamido-substituted pyrrol-1-yl)alkyl]-4-hydroxypyran-2-one inhibitors of cholesterol synthesis | |
| US4644070A (en) | Chroman-3-ol compounds | |
| KR850000426A (ko) | 디하이드로 벤조피란 유도체의 제조방법 | |
| MX7660E (es) | Procedimiento para preparar una composicion para inhibir la dulzura | |
| AU717159B2 (en) | New benzofuranone derivatives and a method for producing them | |
| US4062870A (en) | Chroman derivatives | |
| ES2112870T3 (es) | Derivados de acido glicirretico. | |
| NO823537L (no) | Fremgangsmaate for fremstilling av farmakologisk aktive alkan- og alkenderivater | |
| KR900016178A (ko) | 2-치환 n,n'-디트리메톡시벤조일 피페라진, 그의 제조 방법 및 그를 함유하는 치료 조성물 | |
| US4517365A (en) | Isocarbostyril derivative | |
| ES8801252A1 (es) | Procedimiento para la obtencion de piridazinonas sustituidas | |
| PL265699A1 (en) | Method of obtaining novel derivatives of androstanocarboxylic-17 beta acid | |
| KR900014345A (ko) | 대뇌 신경 전달계 질병 치료제 | |
| FI844184A0 (fi) | Isokinolinderivat och foerfarande foer framstaellning daerav. | |
| KR950004034B1 (ko) | 신규한 p-옥시벤조산 유도체, 그의 제조방법 및 그를 유효성분으로서 함유하는 조성물 | |
| KR950009866B1 (ko) | 4-히드록시테트라하이드로피란-2-온 유도체 및 그의 합성에 이용되는 중간체 | |
| JP2877446B2 (ja) | 4―ヒドロキシテトラヒドロピラン―2―オンの誘導体 | |
| KR880011137A (ko) | 혈당 감소제로서의 플루오로옥시란 카복실레이트 | |
| JPH02172958A (ja) | 4―アミノフェノール誘導体 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD1A | Patent lapsed |
Effective date: 19970401 |